Abstract
Recent progress in psychiatric research has accumulated many mouse models relevant to developmental neuropsychiatric disorders using numerous genetic and environmental manipulations. Since the prefrontal cortex (PFC) is essential for cognitive functions whose impairments are central symptoms associated with the disorders in humans, it has become crucial to clarify altered developmental processes of PFC circuits in these mice. To that end, we aimed to understand a sequence of molecular events during normal mouse PFC development. Expression profiles for representative genes covering diverse biological processes showed that while there were little changes in genes for neuroreceptors and synaptic molecules during postnatal period, there were dramatic increases in expression of myelin-related genes and parvalbumin gene, peaking at postnatal day (P) 21 and P35, respectively. The timing of the peaks is different from one observed in the striatum. Furthermore, evaluation of the circuitry maturation by measuring extracellular glutamate in PFC revealed that sensitivity to an NMDA antagonist became adult-like pattern at P56, suggesting that some of maturation processes continue till P56. The trajectory of molecular events in the PFC maturation described here should help us to characterize how the processes are affected in model mice, an important first step for translational research.
Keywords: qRT-PCR, synapse, inhibitory neurons, dopamine, glutamate, myelination
Introduction
The prefrontal cortex (PFC) is a pivotal brain region for executive cognitive functions, including working memory, planning, reasoning, and decision-making [1]. Acquisition of these higher brain functions depends on development and maturation of PFC, which take decades to complete in humans [2-4]. PFC development and maturation involve diverse biological processes, namely synapse formation, local circuitry formation, connectivity among several brain regions through long projections (network formation), formation of neuromodulation networks, activity-dependent synaptic modulation and plasticity, and myelination. These processes should proceed in a coordinated and sequential manner, each process affecting others [5].
Impairments in cognitive functions are central symptoms associated with developmental neuropsychiatric disorders such as schizophrenia [6]. As etiology of schizophrenia, developmental hypothesis has been proposed, in which combinations of genetic and environmental factors cause alterations in developmental processes that serve as biological basis for pathogenesis of the disorder [7, 8]. In schizophrenia, PFC development is presumed to be disrupted, resulting in cognitive impairments even before the onset of the disorder (so-called prodromal period) [9]. Brains with schizophrenia also show changes associated with many systems including dopamine, glutamate, GABA, and myelin [10].
Recent human genetics studies have provided us with a list of candidate genes involved in disorders like autism and schizophrenia [11-13]. Subsequently, a number of mouse models with modification of those genes have been developed, many of which display behavioral phenotypes relevant to human psychiatric disorders [14-16]. To understand biological processes affected in these animals that can be translated into cognitive impairments in the disorders in humans [17], it is crucial to understand a developmental trajectory of PFC in mice [5]. In the present study, we characterized a sequence of molecular events in developing mouse PFC using gene expression profiles as molecular signatures for developmental processes.
Materials and Methods
Animals
All animals used in this study were treated in accordance with the guidelines for the Animal Care and Use Committee of Kyoto University and Johns Hopkins University. Wild type C57BL/6JJcl mice were purchased from CLEA Japan (Tokyo, Japan) for qRT-PCR and Charles River Laboratories (Wilmington, MA, USA) for in vivo microdialysis. PV/myrGFP-LDLRct mice in the C57BL/6JJcl background that express myristoylated GFP fused with the low density lipoprotein receptor (LDLR) cytoplasmic region under the parvalbumin (PV) gene promoter were previously described [18].
RNA preparation and qRT-PCR analysis
Brain regions of interest were identified using the atlas of Paxinos and Franklin [19] and were collected from 1 mm-thick brain slices with an 1.2 mm-diameter tissue puncher (Supplemental Fig.). Total RNAs from medial PFC and striatum were extracted using RNeasy Mini Kit (QIAGEN) and cDNAs were synthesized using ReverTra Ace qPCR RT Master Mix (TOYOBO). Quantitative real-time PCR was performed using the 7900HT Fast Real-Time PCR System (Applied Biosystems) or ViiA™7 Real-Time PCR System (Applied Biosystems) with THUNDERBIRD Probe qPCR Mix (TOYOBO) and Universal ProbeLibrary (Roche) [20]. Primers were designed using the Universal ProbeLibrary Assay Design Center (Roche; Table). All samples were run in triplicate and for each gene, relative gene expression levels to the level at postnatal day 7 (P7) were calculated using the ΔΔCt method normalized with Gapdh as an endogenous control gene.
Table.
List of primers and Universal Probe sets used for qRT-PCR
| Gene | Forward/Reverse primer | Universal Probe No. |
|---|---|---|
| Control | ||
| Gapdh | gccaaaagggtcatcatctc/cacacccatcacaaacatgg | 29 |
|
| ||
| Neuroreceptors | ||
| Gria1 | agggatcgacatccagagag/tgcacatttcctgtcaaacc | 62 |
| Gria2 | cagtttcgcagtcaccaatg/acccaaaaatcgcatagacg | 32 |
| Gria3 | agccgtgtgatacgatgaaa/caaggtttacaggcgttcct | 31 |
| Gria4 | ctgccaacagttttgctgtg/aaatggcaaacacccctcta | 48 |
| Grin1 | ggagacgttgctggaggag/tcttggttcctgggtcaaac | 13 |
| Grin2a | cctttgtggagacaggaatca/aaggggaaacagtgccatta | 80 |
| Grin2b | aatacagagaacgaaacctcgact/aaagcgcattgctttcgtat | 38 |
| Drd1a | tctggtttacctgatccctca/gcctcctccctcttcaggt | 82 |
| Drd2 | gtcaacaccaagcgtagcag/tcagggtgggtacagttgc | 21 |
| Drd4 | ccatcagcgtggacaggt/acacaccactggcgaagc | 66 |
| Drd5 | tcctggtgtgcttatgctttc/tcagctaagaatcgtttggtttc | 18 |
|
| ||
| Synaptic components | ||
| Psd95 | ggcgcacaagttcattgag/tgagacatcaaggatgcagtg | 83 |
| Shank3 | tggttggcaagagatccat/ttggccccatagaacaaaag | 1 |
| Fmr1 | cacagagacgaactcagtgattg/ctctgcgcaggaagctct | 6 |
| Cyfip1 | ccacacgctacaactacacca/gcctttgatcatggcaatc | 22 |
| Nrcam | cacaccttaatccccacca/ccaccagatgatccttgtca | 5 |
| Nfasc | ccaaagaagaagatggctcatt/catagtccaccaggctgtca | 18 |
| Cntn1 | gagcaaagggacggagtg/ccaagctaccatcttcccata | 84 |
| Cntn2 | gggagcctgtgctacaagac/gctttccagtagcgaatctca | 88 |
| Cntnap1 | gctggggctactacggttg/ccagagaccgtgcatacaga | 17 |
| Cntnap2 | cctacaaagatcacctgccagt/tgagccttgtcggtcagtatc | 77 |
|
| ||
| GABAergic interneurons | ||
| Gad1 | atacaacctttggctgcatgt/ttccgggacatgagcagt | 27 |
| PV | ggcaagattggggttgaag/agcagtcagcgccacttag | 83 |
| Sst | cccagactccgtcagtttct/gggcatcattctctgtctgg | 53 |
| Vip | gcctctctttggaccacctt/ctccttcaaacggcatcct | 42 |
|
| ||
| Oligodendrocyte/myelin | ||
| Sox10 | ctgtctccccatctcctgtc/aaataaaggggcagcgatgt | 26 |
| Olig2 | agaccgagccaacaccag/aagctctcgaatgatccttcttt | 21 |
| Plp1 | gcatttgcccaaatctgc/gcgaaagatccttgctttga | 7 |
| Cldn11 | gcctggagtggccaagta/agccagcagaataaggagca | 20 |
| Cnp1 | cgctggggcagaagaatac/aaggccttgccatacgatct | 10 |
| Mag | tctacccgggattgtcactg/gcagcctcctctcagatcc | 45 |
Histology
Mice were anesthetized with a mixture of ketamine and xylazine and transcardially perfused with phosphate-buffered saline (PBS) followed by 4% paraformaldehyde in PBS. Isolated brains were post-fixed overnight and 50 μm-thick coronal sections were prepared using a vibratome VT1200S (Leica). The sections were washed with PBS and mounted with VECTASHIELD Mounting Medium with DAPI (VECTOR LABORATORIES). Fluorescent images were acquired using an all-in-one fluorescence microscope BZ-9000 (KEYENCE). We counted all GFP-positive cells in both layer 2/3 and layer 5/6 of area 24 in all sections ranging from a brain section containing the rostral end of corpus callosum connecting two hemispheres to a brain section containing the posterior crus of anterior commissure connecting two hemispheres.
Microdialysis
Microdialysis was carried out as previously described [21], with minor modifications. A guide cannula (AG-6, Eicom) was implanted into the frontal cortex (15° angle from anteroposterior, +1.7 mm (P56 and P140), +1.65 mm (P42), +1.5 mm (P28); mediolateral, −1.0 mm (P56 and P140), −0.9 mm (p42), −0.6 mm (P28) from bregma; dorsoventral, −2.0 mm (P56 and P140), −1.8 mm (P42), −1.65 mm (P28) from the dura) according to the atlas of Paxinos and Franklin [19]. Ringer’s solution (147 mM NaCl, 4 mM KCl, and 2.3 mM CaCl2) was perfused at a flow rate of 1.0 μl/min. The samples were collected every 10 min from awake, freely moving mice and analyzed by an HPLC system (Eicom). Six samples were taken to establish the baseline measurement of the extracellular glutamate. The levels of extracellular glutamate were analyzed after the intraperitoneal injection of MK-801 (1 mg/kg).
Results
To gain insights into biological events during PFC development, we performed gene expression analysis by qRT-PCR targeting representative genes for multiple neural components, namely, neurotransmitter receptors, synaptic components, GABAergic interneurons, and oligodendrocyte/myelin (Table). We chose five postnatal time points: P7, P14 (two time points before weaning), P21 (weaning), P35 (adolescence), and P63 (adult).
Glutamate receptors and synaptic components in developing PFC
Neurotransmitter receptors are central players for neurotransmission and critical for synaptic functions. We focused on two types of glutamate receptors, NMDAR and AMPAR, two major receptor types for excitatory synaptic transmissions. All of AMPARs analyzed did not show notable changes in their expressions during the course of development and maturation (Fig. 1A). The NMDARs are heterotetrameric complexes comprised of two NR1 and two NR2 subunits, and among NR2s, NR2A and NR2B are the predominant subunits expressed in the cortex. Grin1 showed 4 fold reduction of its expression at P14 from P7 and stayed at this level, whereas Grin2a showed 4 fold increase of its expression at P14 and stayed at that level. Grin2b showed gradual decrease of its expression, though not so drastically throughout development (Fig. 1B). It has been observed that changes in the composition of NMDAR subunits, namely switching from NR2B to NR2A, take place at early postnatal stage [22]. Gene expression patterns we observed may correspond to this switching event. Next, we have characterized gene expression patterns for a neuromodulatory system, namely dopamine receptors (DRDs), which are targets of most of antipsychotics effective for positive symptoms of schizophrenia [23]. Among the five DRDs, we could not detect the sufficient amplification signals in PFC for Drd3 which has been shown to be predominantly expressed in limbic regions of the brain [24]. Most of DRDs analyzed showed slight reduction of their expressions except Drd4 which showed slight increase of its expression during development (Fig. 1C).
Fig. 1.
Gene expression profiles in developing PFC. (A) AMPARs, (B) NMDARs, (C) DRDs, (D) PSD molecules, (E) CAMs, (F) interneuron-related genes, (G) oligodendrocyte/myelin-related genes (see Table). The endogenous control gene, Gapdh, was used for normalization. Data are means of three independent samples for each point.
We have characterized several synaptic components as markers for synaptic development and maturation. Scaffolding proteins at the postsynaptic density (PSD) are crucial structural components important for anchoring synaptic proteins like channels, receptors, and synaptic cell adhesion molecules (CAMs) [25]. We chose two representatives, Psd95 and Shank3 because the recent findings suggested that there might be differential synaptic localizations of these molecules, at least in humans [26]. Fmr1 and Cyfip1 are important translational modulators at synapses whose alterations are associated with developmental neuropsychiatric disorders [27]. All these four genes did not show any notable differences at all five time points (Fig. 1D). CAMs are key players for supporting synaptic connections [28] and are also involved in neuron-glial interactions, e.g., myelination [29]. Most of CAMs analyzed did not show drastic changes in the expressions during development of PFC except Cntnap1 which plays a role in the formation of myelinated nerve structures [30]. Cntnap1 increased its expression at P14 by 4 fold from P7 and gradually increased its expression thereafter (Fig. 1E).
GABAergic inhibitory interneurons in developing PFC
GABAergic inhibitory interneurons are essential components for local circuitry. Proper excitatory/inhibitory balance determined by activities of excitatory and inhibitory neurons is crucial for regulating an activity of the local circuitry that serves as a module in the neuronal networks, necessary for higher brain functions (e.g., [31, 32]). Although all these interneuron population share a common character, i.e., using GABA as their neurotransmitter, they are comprised of diverse groups of neurons. Recent studies classified GABAergic interneurons based on morphology, molecular profiling, and electrical properties into three major subclasses such as PV-positive fast-spiking neurons, somatostatin (Sst)-positive burst-spiking neurons, and vasoactive intestinal peptide (Vip)-positive regular-spiking neurons [33]. When we characterized expression of the glutamate decarboxylase 1 (Gad1) gene, a marker gene for all GABAergic interneurons, we did not detect dynamic changes during development. However, when we analyzed the cell type-specific profiles, we found quite different pictures. Expression of the PV gene was drastically increased between P7 and P21 (about 256 fold) and reached the peak level at P35. The Vip gene showed 4 fold increase between P7 and P21, and peaked at P35. The Sst gene did not show drastic changes (Fig. 1F). These data suggest that the appearance of the PV-positive neurons in PFC drastically increases between P7 and P21. To confirm this, we analyzed transgenic mice expressing myristoylated GFP under the promoter of the PV gene. The PV-positive interneurons comprised of basket cells and chandelier cells are localized in the upper (layer 2/3) and lower (layer 5/6) layers in mouse PFC. Consistent with the above gene expression data, the total number of GFP-positive cells increased between P21-P35 in both layer 2/3 and 5/6 in PFC (Fig. 2A, B).
Figure 2.
Appearance of PV-positive cells in developing PFC. The total number of GFP-positive (GFP+) cell in (A) layer 2/3 and (B) layer 5/6 of anterior cingulate cortex (area 24) of PV/myrGFP-LDLRct mice that express GFP under the PV gene promoter were counted as described in Materials and Methods. Data are means ± SEM of two independent samples for each point.
Myelin and oligodendrocytes in developing PFC
A local circuitry itself serves as a module that needs to be connected with other modules spread over the brain in order to function in the networks. This is achieved by long projections connecting among these modules. This configuration is the basis for neural networks that are crucial for behavioral tasks [34]. Long projections support a fast neural transmission along the pathways to ensure proper information processing through networks, which is achieved by their myelination by oligodendrocytes [35]. Transmitted signals through the myelinated long projections affect the nature of inputs to the local circuitry, modulating maturation of the local circuitry activity, and therefore, myelination/oligodendrocyte development in PFC must be correlated with the maturation processes of PFC. We characterized expression profiles of several oligodendrocyte/myelin-related genes in developing PFC. Two transcription factors, Olig2 and Sox10, controlling differentiation of oligodendrocytes [36, 37] did not show significant changes. However, myelin components, such as Plp1 and Mag showed drastic increases (64 fold) between P7 and P21 and reached peak level at P21. Other components important for the formation of the myelinated nerve structure such as Cldn11 and Cnp1 also showed increases (4-8 fold) with a similar time course (Fig. 1G).
MK-801 sensitivity of developing PFC
Above results suggest that maturation of PFC may continue at least till P35 when the PV gene expression reaches the maximum level. The systemic administration of an NMDAR antagonist, MK-801, increases the glutamate efflux in PFC [38] and the sensitivity to NMDAR antagonists is thought to reflect physiological properties of neural circuitry (e.g., [39]). Therefore, to clarify the timing of functional maturation of PFC, we investigated the responsiveness to MK-801 administration by measuring the extracellular glutamate level in mouse PFC using in vivo microdialysis. We analyzed four different time points, P28, P42, P56 (three time points during adolescence), and P140 (adult). The level of extracellular glutamate was lower at P28 compared to the adult level, but reached the similar level to adult by P42 (data not shown). However, the response of glutamate release to MK-801 administration was more exaggerated at P42 than the response in adult. At P56, the response became similar to the one at P140 (Fig. 3). These results suggest that functional circuitry maturation in PFC involving NMDAR may be achieved by P56, far beyond P42.
Figure 3.

Measurement of extracellular glutamate in the frontal cortex. The changes in the extracellular glutamate level after MK-801 administration were monitored by in vivo microdialysis. Data are means ± SEM (n = 10-14 for each group). Statistical significance are determined using one-way ANOVA and subsequent Fisher’s PLSD for multiple comparisons. **P < 0.01.
Gene expression patterns during postnatal development of striatum
Since striatum is another place that is presumed to be affected in developmental neuropsychiatric disorders like schizophrenia [40], it was of interest to compare developing patterns in striatum to the ones in PFC. We performed the same gene expression analysis using mouse striatum during the same time period as above. The patterns of AMPARs, NMDARs, and synaptic components are more or less the same with the ones observed in PFC (Fig. 4A, B, and D). DRDs showed similar patterns except Drd4 which showed a more pronounced reduction at P21 (Fig. 4C). CAMs also showed similar trends of the expression changes (though there are some differences quantitatively) during development (Fig. 4E). However, expression of interneuron genes showed quite different patterns. There were increases by 16 fold both in the PV and Vip gene expressions between P7 and P14, but the expressions went down thereafter (Fig. 4F). Furthermore, the oligodendrocyte/myelin-related genes showed quite distinct patterns from those in PFC. Whereas Olig2 and Sox10 showed similar patterns to the ones in PFC, genes such as Plp1, Mag, Cldn11, and Cnp1 increased their expressions and reached maximum levels by P14 (Fig. 4G).
Figure 4.
Gene expression profiles in developing striatum. (A) AMPARs, (B) NMDARs, (C) DRDs, (D) PSD molecules, (E) CAMs, (F) interneuron-related genes, (G) oligodendrocyte/myelin-related genes (see Table). The endogenous control gene, Gapdh, was used for normalization. Data are means of three independent samples for each point.
These results implicate that expression changes during development show regional differences, and that PFC seems to have a slower time course of maturation than striatum, based on the expression of interneuron genes and myelin-related genes. It has been shown that neuronal maturation as well as myelination in human PFC is slower compared to any other brain regions [41, 42]. Our data support an idea that this may be applied to rodent’s PFC as well.
Discussion
Developmental neuropsychiatric disorders such as schizophrenia show impairments in cognitive functions that are mediated by PFC (e.g., working memory, [43]). Developmental processes of PFC may be affected by a combination of genetic and environmental factors, serving as biological bases for pathogenesis of the disorder [8, 44]. Establishment of functional neural circuits requires temporally coordinated multiple biological processes, including neurogenesis, migration of newborn neurons, neurite outgrowth, gliogenesis, synaptogenesis, myelination, synapse maturation and elimination [45]. In the present study, we focused on the processes taking place postnatally, namely synaptogenesis, activity-dependent synaptic modulation, development of neuromodulation (dopamine), and myelination during development and maturation of PFC, focusing on processes relevant to pathophysiology of the disorders.
Gene expression profiles in developing PFC
Neuronal activity in local circuitry depends on glutamatergic neurons. It has been shown that during maturation, there is a subunit switch in NR2 components, namely NR2A and NR2B [22]. We detected changes in expression of genes for these subunits at early postnatal ages that may reflect this subunit switch. However, at P14 glutamate receptors already showed similar expression patterns to the ones in the mature brain.
Cognitive functions involving the local circuitry require maintaining an appropriate excitatory/inhibitory balance (e.g., [46]), in which GABAergic interneurons play crucial roles. In the present study, individual GABAergic interneuron populations show distinct patterns of the gene expression profile. Especially, the PV gene showed a unique pattern, drastically increasing its expression with a peak at P35. Maturation of PV neurons depends on appropriate inputs from pyramidal neurons [47], a process dependent on NMDAR on the PV neurons [48]. These data imply that maturation of the PV neurons is well correlated with local circuitry maturation. The local circuitry maturation in turn should be correlated with functional measurements of PFC, such as gamma oscillation [49]. Altered gamma oscillation is reported in schizophrenia [32], possibly underscoring the importance of maturation of the PV neurons in schizophrenia pathogenesis.
When we characterized expression patterns of the oligodendrocyte/myelin-related genes, we found that the Mag and Plp1 genes whose products are directly involved in myelin sheath formation increased notably their expressions during development of PFC. It has been shown that the degree of myelination depends on the neuronal activity of the axons that are wrapped by oligodendrocytes [50]. These data support an idea that maturation of neuronal activity in the PFC circuits induces maturation of myelination of the PFC neurons. In addition, the degree of myelination should also affect maturation of the local circuitry activity, having bi-directional interactions. A recent report demonstrating that complicated motor skill learning requires active central myelination in corpus callosum by using a specific blockade of the production of new oligodendrocytes in adults [51] underscores the importance of myelination in maturation of brain functions.
When we characterized the extracellular glutamate level in PFC, the similar level to adult was already observed at P42. However, the response of glutamate release in the frontal cortex to the systemic MK-801 administration was still exaggerated at P28 and P42, and became similar to adult at P56. This suggests that although gene expression patterns of glutamate and inhibitory neurons as well as myelination become similar to the adult ones at P35, the circuitry is still functionally immature. At this moment, we do not know what correlates with this time period vulnerable to MK-801, gene expression wise, but possible candidates of biological processes taking place during this late maturation period would be ongoing synaptic pruning, functional maturation of inhibitory neurons, and/or maturation of neuromodulation such as dopamine system.
Behaviorally, mice have developmental milestones reflecting acquisition/disappearance of different abilities/tendencies at certain ages that have been described in many behavioral tasks such as novel object recognition tasks [52]. At P21, mice exhibit object exploration comparable to adults, but they are unable to detect either object rearrangement or object novelty. At P28, mice show higher locomotion activity and object exploration and are able to detect the spatial rearrangement though they do not display preference for the displaced objects (which adult mice would do). They also clearly react to object novelty. At P49 (which is equivalent to adolescence), mice show the highest levels of object exploration and are able to detect the spatial rearrangement, but still do not display any preference for the displaced objects. They also react to object novelty. Although spatial learning is mediated by hippocampus, some of these features may also be associated with PFC development. Moreover, it has been shown that at P42-56, mice can perform well in Y-maze and object based attention tests [53], supporting an idea that abilities of working memory and attention, features mediated by PFC, are established around this time period.
As for social behavior, another brain function involving PFC, adults are mainly concerned with dominance/submission and reproductive matters, spending most of their social time in patrolling, fighting, copulating, and raising litters. However, developing mice (namely P21-45) engage in frequent and prolonged bouts of amicable and playful behavior [54]. This complex and subtle domain of social activity seems to have a prominent role in the development and refinement of species-specific behavioral repertoire (from motor to cognitive and social skills) [54]. Development of some of these social behaviors may also be associated with PFC development.
When we compare gene expression profile of developing PFC with that of developing striatum, the timing of the peaks is different for interneuron and myelin genes (compare Fig. 1 and Fig. 4). Furthermore, even in the cerebral cortex, the patterns seem to be different from the ones in motor and sensory cortices (unpublished results). These results suggest that PFC has unique developmental profiles of gene expression, perhaps reflecting different timing of maturation of biological processes.
Gene expression and functional outcomes: molecular targets for translation
The gene expression profiles can be used as molecular signatures of biological processes during development of PFC. Many mouse models with modified genes that are associated with developmental neuropsychiatric disorders like autism and schizophrenia have been developed and characterized. Analyses of PFC in those mice showed a wide range of changes including synaptic dysfunction, decreased PV interneurons, alterations in excitatory/inhibitory balance, and myelination deficits (e.g., [20, 55-63]). Using the molecular signatures described here, it will become possible for us to identify pathological chains of events introduced in those animals, which may lead to behavioral alterations, namely cognitive deficits. Once we identify critical biological events that are affected in these mouse models, we could devise therapeutic approaches to correct those biological events, by which we may be able to improve behavioral deficits (e.g., [64-69]).
Interestingly, the onset of schizophrenia in humans is usually in late teens and early twenties. It is believed that during adolescence, brain receives impacts from environmental insults, resulting in dysfunction in the system that manifests as psychosis episodes (onset of the disorders). In case of mice, adolescence corresponds to the time period from weaning to adult (P28-P56). PFC has extended period sensitive to the detrimental effects of stress exposure [70] and our data suggest that the time window for environmental insults to PFC remains open at least till P56 in mice. It has been shown that social isolation during P21-P35 affected PFC myelination and induced behavioral alterations, whereas social isolation during P35-P56 did not affect PFC myelination nor induce those behavioral alterations observed in the former isolation condition [71]. Interestingly, social isolation during P35-P56 affected gene expression patterns in mesocortical, but not mesolimbic dopaminergic system through the hypothalamic-pituitary-adrenal (HPA) axis, i.e., stress response, and showed behavioral alterations in different domains [21]. The former time period corresponds to the period of myelin maturation (P21-P35), whereas the latter time period corresponds to the period of the late circuitry maturation predicted in this study (P35-P56). This suggests that different insults (combined with different time period) may affect different biological processes during PFC maturation, which may lead to different behavioral phenotypes.
Recently, prodromal period of schizophrenia has been identified, in which impaired brain circuitry and functions are present before the disease onset [72, 73]. By identifying critical changes in the brain during prodromal period, we could develop early intervention to prevent the onset of the disorders, i.e., psychosis. Longitudinal studies using brain imaging showed that high risk population for schizophrenia developed progressive brain volume loss over time [74-76], which may be used as indicators for early intervention for the population. There are numerous studies using brain imaging, trying to pinpoint biological nature of these events (e.g., [77]). It would be necessary to characterize both preclinical and clinical models in parallel [17], and by characterizing the animal models along the developmental trajectory of PFC described here, we should be able to clarify molecular signatures of prodromal phenotypes that may be translated into humans as useful biomarkers.
Conclusion
We have provided with basic information of molecular profiles in developing mouse PFC that may correlate with maturation level of the brain region. Compared with similar information identified in primates (e.g., [78, 79]), the results provided here in mice should be useful when we characterize PFC of mouse models for developmental neuropsychiatric disorders in order to understand pathophysiology of disorders as well as biological nature of the prodromal state of schizophrenia.
Supplementary Material
Supplemental Figure legend Illustrations of mouse brain slices used for RNA purification. 1.2 mm-diameter circles show the brain regions punched out as medial PFC and striatum.
Acknowledgement
Our work performed at the Open Innovation Laboratory for Drug Discovery and Development by Takeda and Kyoto University “ Basic and Clinical Research Project for CNS Drugs” was supported in part by Takeda Pharmaceutical Co. Ltd. In addition, AS and MN are supported by NIH (MH-084018, MH-094268 Silvio O. Conte Center, MH-069853, MH-085226, MH-088753, and MH-092443 to AS; K99MH-094408 to MN) and TS, HH, JS, and TK are supported by Grants from Ministry of Education, Culture, Sports, Science and Technology in Japan/Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (25116516 and 25350987 to TS; 25123709, 22110007, and 24500408 to HH; 13J01992 to JS; 23115101 and 25250006 to TK). JS is a Research Fellow of Japan Society for the Promotion of Science. We thank Medical Research Support Center at Kyoto University Graduate School of Medicine for the fluorescence microscopy (supported by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology in Japan) and Drs. Hikida and Tomoda of Medical Innovation Center for critical reading and comments.
Footnotes
Conflict of Interest
The authors declare that there are no conflicts of interest regarding this article.
References
- 1.Fuster JM. The Prefrontal Cortex. Fourth edition Elsevier; 2008. [Google Scholar]
- 2.Giedd JN. Structural magnetic resonance imaging of the adolescent brain. Ann N Y Acad Sci. 2004;1021:77–85. doi: 10.1196/annals.1308.009. [DOI] [PubMed] [Google Scholar]
- 3.Raznahan A, Lerch JP, Lee N, Greenstein D, Wallace GL, Stockman M, Clasen L, Shaw PW, Giedd JN. Patterns of coordinated anatomical change in human cortical development: a longitudinal neuroimaging study of maturational coupling. Neuron. 2011;72:873–84. doi: 10.1016/j.neuron.2011.09.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Miller DJ, Duka T, Stimpson CD, Schapiro SJ, Baze WB, McArthur MJ, Fobbs AJ, Sousa AM, Sestan N, Wildman DE, Lipovich L, Kuzawa CW, Hof PR, Sherwood CC. Prolonged myelination in human neocortical evolution. Proc Natl Acad Sci U S A. 2012;109:16480–5. doi: 10.1073/pnas.1117943109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Catts VS, Fung SJ, Long LE, Joshi D, Vercammen A, Allen KM, Fillman SG, Rothmond DA, Sinclair D, Tiwari Y, Tsai SY, Weickert TW, Shannon Weickert C. Rethinking schizophrenia in the context of normal neurodevelopment. Front Cell Neurosci. 2013;7:60. doi: 10.3389/fncel.2013.00060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kahn RS, Keefe RS. Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry. 2013;70:1107–12. doi: 10.1001/jamapsychiatry.2013.155. [DOI] [PubMed] [Google Scholar]
- 7.Weinberger DR. On the plausibility of “the neurodevelopmental hypothesis” of schizophrenia. Neuropsychopharmacology. 1996;14:1S–11S. doi: 10.1016/0893-133X(95)00199-N. [DOI] [PubMed] [Google Scholar]
- 8.Insel TR. Rethinking schizophrenia. Nature. 2010;468:187–93. doi: 10.1038/nature09552. [DOI] [PubMed] [Google Scholar]
- 9.Lieberman JA. Neurobiology and the natural history of schizophrenia. J Clin Psychiatry. 2006;67:e14. [PubMed] [Google Scholar]
- 10.Weinberger DR, J . HP: Schizophrenia. Third Edition WIley-Blackwell; Chichester, West Sussexx, UK: 2011. [Google Scholar]
- 11.Hall J, Trent S, Thomas KL, O’Donovan MC, Owen MJ. Genetic Risk for Schizophrenia: Convergence on Synaptic Pathways Involved in Plasticity. Biol Psychiatry. 2014 doi: 10.1016/j.biopsych.2014.07.011. [DOI] [PubMed] [Google Scholar]
- 12.Schizophrenia Working Group of the Psychiatric Genomics C Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7. doi: 10.1038/nature13595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, Kou Y, Liu L, Fromer M, Walker S, Singh T, Klei L, Kosmicki J, Shih-Chen F, Aleksic B, Biscaldi M, Bolton PF, Brownfeld JM, Cai J, Campbell NG, Carracedo A, Chahrour MH, Chiocchetti AG, Coon H, Crawford EL, Curran SR, Dawson G, Duketis E, Fernandez BA, Gallagher L, Geller E, Guter SJ, Hill RS, Ionita-Laza J, Jimenz Gonzalez P, Kilpinen H, Klauck SM, Kolevzon A, Lee I, Lei I, Lei J, Lehtimaki T, Lin CF, Ma’ayan A, Marshall CR, McInnes AL, Neale B, Owen MJ, Ozaki N, Parellada M, Parr JR, Purcell S, Puura K, Rajagopalan D, Rehnstrom K, Reichenberg A, Sabo A, Sachse M, Sanders SJ, Schafer C, Schulte-Ruther M, Skuse D, Stevens C, Szatmari P, Tammimies K, Valladares O, Voran A, Li-San W, Weiss LA, Willsey AJ, Yu TW, Yuen RK, Study DDD. Homozygosity Mapping Collaborative for A. Consortium UK. Cook EH, Freitag CM, Gill M, Hultman CM, Lehner T, Palotie A, Schellenberg GD, Sklar P, State MW, Sutcliffe JS, Walsh CA, Scherer SW, Zwick ME, Barett JC, Cutler DJ, Roeder K, Devlin B, Daly MJ, Buxbaum JD. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014;515:209–15. doi: 10.1038/nature13772. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Young JW, Zhou X, Geyer MA. Animal models of schizophrenia. Curr Top Behav Neurosci. 2010;4:391–433. doi: 10.1007/7854_2010_62. [DOI] [PubMed] [Google Scholar]
- 15.Kas MJ, Glennon JC, Buitelaar J, Ey E, Biemans B, Crawley J, Ring RH, Lajonchere C, Esclassan F, Talpos J, Noldus LP, Burbach JP, Steckler T. Assessing behavioural and cognitive domains of autism spectrum disorders in rodents: current status and future perspectives. Psychopharmacology (Berl) 2014;231:1125–46. doi: 10.1007/s00213-013-3268-5. [DOI] [PubMed] [Google Scholar]
- 16.Silverman JL, Yang M, Lord C, Crawley JN. Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci. 2010;11:490–502. doi: 10.1038/nrn2851. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Sawa A, Seidman LJ. Is prophylactic psychiatry around the corner? combating adolescent oxidative stress for adult psychosis and schizophrenia. Neuron. 2014;83:991–3. doi: 10.1016/j.neuron.2014.08.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kameda H, Hioki H, Tanaka YH, Tanaka T, Sohn J, Sonomura T, Furuta T, Fujiyama F, Kaneko T. Parvalbumin-producing cortical interneurons receive inhibitory inputs on proximal portions and cortical excitatory inputs on distal dendrites. Eur J Neurosci. 2012;35:838–54. doi: 10.1111/j.1460-9568.2012.08027.x. [DOI] [PubMed] [Google Scholar]
- 19.Paxinos G, Franklin KBJ. Paxinos and Franklin’s the Mouse Brain in Stereotaxic Coordinates. Fourth Edition Academic Press; 2012. [Google Scholar]
- 20.Takahashi N, Sakurai T, Bozdagi-Gunal O, Dorr NP, Moy J, Krug L, Gama-Sosa M, Elder GA, Koch RJ, Walker RH, Hof PR, Davis KL, Buxbaum JD. Increased expression of receptor phosphotyrosine phosphatase-beta/zeta is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes. Transl Psychiatry. 2011;1:e8. doi: 10.1038/tp.2011.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Niwa M, Jaaro-Peled H, Tankou S, Seshadri S, Hikida T, Matsumoto Y, Cascella NG, Kano S, Ozaki N, Nabeshima T, Sawa A. Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science. 2013;339:335–9. doi: 10.1126/science.1226931. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Liu XB, Murray KD, Jones EG. Switching of NMDA receptor 2A and 2B subunits at thalamic and cortical synapses during early postnatal development. J Neurosci. 2004;24:8885–95. doi: 10.1523/JNEUROSCI.2476-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Miyamoto S, Miyake N, Jarskog LF, Fleischhacker WW, Lieberman JA. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. Mol Psychiatry. 2012;17:1206–27. doi: 10.1038/mp.2012.47. [DOI] [PubMed] [Google Scholar]
- 24.Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 1990;347:146–51. doi: 10.1038/347146a0. [DOI] [PubMed] [Google Scholar]
- 25.Nithianantharajah J, Komiyama NH, McKechanie A, Johnstone M, Blackwood DH, St Clair D, Emes RD, van de Lagemaat LN, Saksida LM, Bussey TJ, Grant SG. Synaptic scaffold evolution generated components of vertebrate cognitive complexity. Nat Neurosci. 2013;16:16–24. doi: 10.1038/nn.3276. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Shcheglovitov A, Shcheglovitova O, Yazawa M, Portmann T, Shu R, Sebastiano V, Krawisz A, Froehlich W, Bernstein JA, Hallmayer JF, Dolmetsch RE. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature. 2013;503:267–71. doi: 10.1038/nature12618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Fernandez E, Rajan N, Bagni C. The FMRP regulon: from targets to disease convergence. Front Neurosci. 2013;7:191. doi: 10.3389/fnins.2013.00191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Bukalo O, Dityatev A. Synaptic cell adhesion molecules. Adv Exp Med Biol. 2012;970:97–128. doi: 10.1007/978-3-7091-0932-8_5. [DOI] [PubMed] [Google Scholar]
- 29.Poliak S, Peles E. The local differentiation of myelinated axons at nodes of Ranvier. Nat Rev Neurosci. 2003;4:968–80. doi: 10.1038/nrn1253. [DOI] [PubMed] [Google Scholar]
- 30.Bhat MA, Rios JC, Lu Y, Garcia-Fresco GP, Ching W, St Martin M, Li J, Einheber S, Chesler M, Rosenbluth J, Salzer JL, Bellen HJ. Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV/Caspr/Paranodin. Neuron. 2001;30:369–83. doi: 10.1016/s0896-6273(01)00294-x. [DOI] [PubMed] [Google Scholar]
- 31.Takesian AE, Hensch TK. Balancing plasticity/stability across brain development. Prog Brain Res. 2013;207:3–34. doi: 10.1016/B978-0-444-63327-9.00001-1. [DOI] [PubMed] [Google Scholar]
- 32.Uhlhaas PJ, Singer W. High-frequency oscillations and the neurobiology of schizophrenia. Dialogues Clin Neurosci. 2013;15:301–13. doi: 10.31887/DCNS.2013.15.3/puhlhaas. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Kepecs A, Fishell G. Interneuron cell types are fit to function. Nature. 2014;505:318–26. doi: 10.1038/nature12983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.van den Heuvel MP, Fornito A. Brain networks in schizophrenia. Neuropsychol Rev. 2014;24:32–48. doi: 10.1007/s11065-014-9248-7. [DOI] [PubMed] [Google Scholar]
- 35.Nave KA. Myelination and support of axonal integrity by glia. Nature. 2010;468:244–52. doi: 10.1038/nature09614. [DOI] [PubMed] [Google Scholar]
- 36.Lu QR, Yuk D, Alberta JA, Zhu Z, Pawlitzky I, Chan J, McMahon AP, Stiles CD, Rowitch DH. Sonic hedgehog--regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron. 2000;25:317–29. doi: 10.1016/s0896-6273(00)80897-1. [DOI] [PubMed] [Google Scholar]
- 37.Stolt CC, Rehberg S, Ader M, Lommes P, Riethmacher D, Schachner M, Bartsch U, Wegner M. Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev. 2002;16:165–70. doi: 10.1101/gad.215802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Bubser M, Tzschentke T, Hauber W. Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats. J Neural Transm Gen Sect. 1995;101:115–26. doi: 10.1007/BF01271550. [DOI] [PubMed] [Google Scholar]
- 39.Gonzalez-Burgos G, Kroener S, Zaitsev AV, Povysheva NV, Krimer LS, Barrionuevo G, Lewis DA. Functional maturation of excitatory synapses in layer 3 pyramidal neurons during postnatal development of the primate prefrontal cortex. Cereb Cortex. 2008;18:626–37. doi: 10.1093/cercor/bhm095. [DOI] [PubMed] [Google Scholar]
- 40.Simpson EH, Kellendonk C, Kandel E. A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron. 2010;65:585–96. doi: 10.1016/j.neuron.2010.02.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Petanjek Z, Judas M, Simic G, Rasin MR, Uylings HB, Rakic P, Kostovic I. Extraordinary neoteny of synaptic spines in the human prefrontal cortex. Proc Natl Acad Sci U S A. 2011;108:13281–6. doi: 10.1073/pnas.1105108108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Hoistad M, Segal D, Takahashi N, Sakurai T, Buxbaum JD, Hof PR. Linking white and grey matter in schizophrenia: oligodendrocyte and neuron pathology in the prefrontal cortex. Front Neuroanat. 2009;3:9. doi: 10.3389/neuro.05.009.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Goldman-Rakic PS. Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci. 1994;6:348–57. doi: 10.1176/jnp.6.4.348. [DOI] [PubMed] [Google Scholar]
- 44.Jaaro-Peled H, Hayashi-Takagi A, Seshadri S, Kamiya A, Brandon NJ, Sawa A. Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends Neurosci. 2009;32:485–95. doi: 10.1016/j.tins.2009.05.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Kandel ER, Schwartz JH, Jessell TM, Siegelbaum SA, Hudspeth AJ. Principles of Neural Science. Fifth Edition McGraw-Hill Professional; 2012. [Google Scholar]
- 46.Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, O’Shea DJ, Sohal VS, Goshen I, Finkelstein J, Paz JT, Stehfest K, Fudim R, Ramakrishnan C, Huguenard JR, Hegemann P, Deisseroth K. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature. 2011;477:171–8. doi: 10.1038/nature10360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Huang ZJ, Kirkwood A, Pizzorusso T, Porciatti V, Morales B, Bear MF, Maffei L, Tonegawa S. BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell. 1999;98:739–55. doi: 10.1016/s0092-8674(00)81509-3. [DOI] [PubMed] [Google Scholar]
- 48.Carlen M, Meletis K, Siegle JH, Cardin JA, Futai K, Vierling-Claassen D, Ruhlmann C, Jones SR, Deisseroth K, Sheng M, Moore CI, Tsai LH. A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol Psychiatry. 2012;17:537–48. doi: 10.1038/mp.2011.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Curley AA, Lewis DA. Cortical basket cell dysfunction in schizophrenia. J Physiol. 2012;590:715–24. doi: 10.1113/jphysiol.2011.224659. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Wake H, Lee PR, Fields RD. Control of local protein synthesis and initial events in myelination by action potentials. Science. 2011;333:1647–51. doi: 10.1126/science.1206998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.McKenzie IA, Ohayon D, Li H, de Faria JP, Emery B, Tohyama K, Richardson WD. Motor skill learning requires active central myelination. Science. 2014;346:318–22. doi: 10.1126/science.1254960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Ricceri L, Colozza C, Calamandrei G. Ontogeny of spatial discrimination in mice: a longitudinal analysis in the modified open-field with objects. Dev Psychobiol. 2000;37:109–18. doi: 10.1002/1098-2302(200009)37:2<109::aid-dev6>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
- 53.Alkam T, Kim HC, Mamiya T, Yamada K, Hiramatsu M, Nabeshima T. Evaluation of cognitive behaviors in young offspring of C57BL/6J mice after gestational nicotine exposure during different time-windows. Psychopharmacology (Berl) 2013;230:451–63. doi: 10.1007/s00213-013-3175-9. [DOI] [PubMed] [Google Scholar]
- 54.Terranova ML, Laviola G. Current Protocols in Toxicology. John Wiley and Sons., Inc.; 2005. Scoring of social interactions and play in mice during adolescence; pp. 1–11. [DOI] [PubMed] [Google Scholar]
- 55.Del Pino I, Garcia-Frigola C, Dehorter N, Brotons-Mas JR, Alvarez-Salvado E, Martinez de Lagran M, Ciceri G, Gabaldon MV, Moratal D, Dierssen M, Canals S, Marin O, Rico B. Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. Neuron. 2013;79:1152–68. doi: 10.1016/j.neuron.2013.07.010. [DOI] [PubMed] [Google Scholar]
- 56.Fenelon K, Xu B, Lai CS, Mukai J, Markx S, Stark KL, Hsu PK, Gan WB, Fischbach GD, MacDermott AB, Karayiorgou M, Gogos JA. The pattern of cortical dysfunction in a mouse model of a schizophrenia-related microdeletion. J Neurosci. 2013;33:14825–39. doi: 10.1523/JNEUROSCI.1611-13.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Yin DM, Sun XD, Bean JC, Lin TW, Sathyamurthy A, Xiong WC, Gao TM, Chen YJ, Mei L. Regulation of spine formation by ErbB4 in PV-positive interneurons. J Neurosci. 2013;33:19295–303. doi: 10.1523/JNEUROSCI.2090-13.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Yin DM, Chen YJ, Lu YS, Bean JC, Sathyamurthy A, Shen C, Liu X, Lin TW, Smith CA, Xiong WC, Mei L. Reversal of behavioral deficits and synaptic dysfunction in mice overexpressing neuregulin 1. Neuron. 2013;78:644–57. doi: 10.1016/j.neuron.2013.03.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Karayannis T, Au E, Patel JC, Kruglikov I, Markx S, Delorme R, Heron D, Salomon D, Glessner J, Restituito S, Gordon A, Rodriguez-Murillo L, Roy NC, Gogos JA, Rudy B, Rice ME, Karayiorgou M, Hakonarson H, Keren B, Huguet G, Bourgeron T, Hoeffer C, Tsien RW, Peles E, Fishell G. Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission. Nature. 2014;511:236–40. doi: 10.1038/nature13248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Bissonette GB, Bae MH, Suresh T, Jaffe DE, Powell EM. Prefrontal cognitive deficits in mice with altered cerebral cortical GABAergic interneurons. Behav Brain Res. 2014;259:143–51. doi: 10.1016/j.bbr.2013.10.051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Bissonette GB, Schoenbaum G, Roesch MR, Powell EM. Interneurons are necessary for coordinated activity during reversal learning in orbitofrontal cortex. Biol Psychiatry. 2015;77:454–64. doi: 10.1016/j.biopsych.2014.07.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Penagarikano O, Abrahams BS, Herman EI, Winden KD, Gdalyahu A, Dong H, Sonnenblick LI, Gruver R, Almajano J, Bragin A, Golshani P, Trachtenberg JT, Peles E, Geschwind DH. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell. 2011;147:235–46. doi: 10.1016/j.cell.2011.08.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Krueger DD, Osterweil EK, Chen SP, Tye LD, Bear MF. Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome. Proc Natl Acad Sci U S A. 2011;108:2587–92. doi: 10.1073/pnas.1013855108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Hayashi-Takagi A, Araki Y, Nakamura M, Vollrath B, Duron SG, Yan Z, Kasai H, Huganir RL, Campbell DA, Sawa A. PAKs inhibitors ameliorate schizophrenia-associated dendritic spine deterioration in vitro and in vivo during late adolescence. Proc Natl Acad Sci U S A. 2014;111:6461–6. doi: 10.1073/pnas.1321109111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Cabungcal JH, Counotte DS, Lewis EM, Tejeda HA, Piantadosi P, Pollock C, Calhoon GG, Sullivan EM, Presgraves E, Kil J, Hong LE, Cuenod M, Do KQ, O’Donnell P. Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia. Neuron. 2014;83:1073–84. doi: 10.1016/j.neuron.2014.07.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Tang G, Gudsnuk K, Kuo SH, Cotrina ML, Rosoklija G, Sosunov A, Sonders MS, Kanter E, Castagna C, Yamamoto A, Yue Z, Arancio O, Peterson BS, Champagne F, Dwork AJ, Goldman J, Sulzer D. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron. 2014;83:1131–43. doi: 10.1016/j.neuron.2014.07.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Penagarikano O, Lazaro MT, Lu XH, Gordon A, Dong H, Lam HA, Peles E, Maidment NT, Murphy NP, Yang XW, Golshani P, Geschwind DH. Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism. Sci Transl Med. 2015;7:271ra8. doi: 10.1126/scitranslmed.3010257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Krueger DD, Bear MF. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med. 2011;62:411–29. doi: 10.1146/annurev-med-061109-134644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Sahin M. Targeted treatment trials for tuberous sclerosis and autism: no longer a dream. Curr Opin Neurobiol. 2012;22:895–901. doi: 10.1016/j.conb.2012.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Arnsten A, Mazure CM, Sinha R. This is your brain in meltdown. Sci Am. 2012;306:48–53. doi: 10.1038/scientificamerican0412-48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Makinodan M, Rosen KM, Ito S, Corfas G. A critical period for social experience-dependent oligodendrocyte maturation and myelination. Science. 2012;337:1357–60. doi: 10.1126/science.1220845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22:353–70. doi: 10.1093/schbul/22.2.353. [DOI] [PubMed] [Google Scholar]
- 73.Seidman LJ, Giuliano AJ, Meyer EC, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Bearden CE, Christensen BK, Hawkins K, Heaton R, Keefe RS, Heinssen R, Cornblatt BA, North American Prodrome Longitudinal Study G Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry. 2010;67:578–88. doi: 10.1001/archgenpsychiatry.2010.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Dazzan P, Soulsby B, Mechelli A, Wood SJ, Velakoulis D, Phillips LJ, Yung AR, Chitnis X, Lin A, Murray RM, McGorry PD, McGuire PK, Pantelis C. Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis. Schizophr Bull. 2012;38:1083–91. doi: 10.1093/schbul/sbr035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Brans RG, van Haren NE, van Baal GC, Staal WG, Schnack HG, Kahn RS, Hulshoff Pol HE. Longitudinal MRI study in schizophrenia patients and their healthy siblings. Br J Psychiatry. 2008;193:422–3. doi: 10.1192/bjp.bp.107.041467. [DOI] [PubMed] [Google Scholar]
- 76.van Haren NE, Hulshoff Pol HE, Schnack HG, Cahn W, Brans R, Carati I, Rais M, Kahn RS. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry. 2008;63:106–13. doi: 10.1016/j.biopsych.2007.01.004. [DOI] [PubMed] [Google Scholar]
- 77.Fusar-Poli P, Howes OD, Allen P, Broome M, Valli I, Asselin MC, Grasby PM, McGuire PK. Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study. Arch Gen Psychiatry. 2010;67:683–91. doi: 10.1001/archgenpsychiatry.2010.77. [DOI] [PubMed] [Google Scholar]
- 78.Hoftman GD, Volk DW, Bazmi HH, Li S, Sampson AR, Lewis DA. Altered Cortical Expression of GABA-Related Genes in Schizophrenia: Illness Progression vs Developmental Disturbance. Schizophr Bull. 2013 doi: 10.1093/schbul/sbt178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Hoftman GD, Lewis DA. Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia. Schizophr Bull. 2011;37:493–503. doi: 10.1093/schbul/sbr029. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplemental Figure legend Illustrations of mouse brain slices used for RNA purification. 1.2 mm-diameter circles show the brain regions punched out as medial PFC and striatum.



